The effect of antithymocyte globulin on abnormal lymphocyte transformation in patients with aplastic anemia.
D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000494:pharmacology* / Q000627:therapeutic use; D001772:Blood Cell Count; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D008934:Mitogens / Q000494:pharmacology; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology; D013997:Time Factors
D000961:Antilymphocyte Serum; D008934:Mitogens